Skip to main content
Figure 6 | BMC Medical Genetics

Figure 6

From: Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype

Figure 6

Immunoblotting in carriers 1 and 8 and Coomassie staining for protein quantification by densitometric analysis. A) Immunoblot with DYS2 antibody (directed against carboxy terminal region of dystrophin) shows protein levels of 15% for carrier 1 and 70% for carrier 8, with respect to control. B) Immunoblot with DYS1 antibody (directed against rod domain) reveals 11% and 87% of normal protein levels for carriers 1 and 8, respectively.

Back to article page